scholarly journals Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors

2012 ◽  
pp. 371-391
Author(s):  
Marco Presta ◽  
Daria Leali ◽  
Helena Stabile ◽  
Roberto Ronca ◽  
Maura Camozzi ◽  
...  
Keyword(s):  
Angiogenesis Inhibitors ◽  
Heparin Derivatives

Heparin Derivatives as Angiogenesis Inhibitors

2003 ◽  
Vol 9 (7) ◽  
pp. 553-566 ◽  
Author(s):  
M. Presta ◽  
D. Leali ◽  
H. Stabile ◽  
R. Ronca ◽  
M. Camozzi ◽  
...  
Keyword(s):  
Angiogenesis Inhibitors ◽  
Heparin Derivatives

Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors

2005 ◽  
Vol 2 (1) ◽  
pp. 371-391
Author(s):  
Marco Presta ◽  
Daria Leali ◽  
Helena Stabile ◽  
Roberto Ronca ◽  
Maura Camozzi ◽  
...  
Keyword(s):  
Angiogenesis Inhibitors ◽  
Heparin Derivatives

Evaluation of Angiogenesis Inhibitors Using the HUVEC Fibrin Bead Sprouting Assay

BIO-PROTOCOL ◽  
2016 ◽  
Vol 6 (19) ◽  
Author(s):  
Laura Winters ◽  
Nithya Thambi ◽  
Julian Andreev ◽  
Frank Kuhnert
Keyword(s):  
Angiogenesis Inhibitors

scholarly journals Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature

2021 ◽  
Vol 28 (1) ◽  
pp. 661-670
Author(s):  
Lawrence Kasherman ◽  
Jeffrey Doi ◽  
Katherine Karakasis ◽  
Jeffrey Schiff ◽  
Abhijat Kitchlu ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Organ Transplant ◽  
Angiogenesis Inhibitors ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Immunosuppressive Medication ◽  
Increased Risk ◽  
Anti Cancer ◽  
Solid Organ Transplant Recipients

Solid organ transplant recipients on long-term immunosuppressive medication are at increased risk of developing malignancy, and treatment of advanced cancers with angiogenesis inhibitors in this context has not been widely studied. We present a case of recurrent high-grade serous ovarian carcinoma treated with paclitaxel and bevacizumab in the context of prior renal transplantation where the patient responded well to treatment with controlled toxicities, discussing the potential for increased rates of adverse events and drug interactions in this select population.

scholarly journals Marine-Derived Angiogenesis Inhibitors for Cancer Therapy

Marine Drugs ◽  
2013 ◽  
Vol 11 (12) ◽  
pp. 903-933 ◽  
Author(s):  
Ying-Qing Wang ◽  
Ze-Hong Miao
Keyword(s):  
Cancer Therapy ◽  
Angiogenesis Inhibitors

Angiogenesis Inhibitors and Anti-Inflammatory Agents from Phoma sp. NTOU4195

2016 ◽  
Vol 79 (12) ◽  
pp. 2983-2990 ◽  
Author(s):  
Ming-Shian Lee ◽  
Shih-Wei Wang ◽  
Guei-Jane Wang ◽  
Ka-Lai Pang ◽  
Ching-Kuo Lee ◽  
...  
Keyword(s):  
Angiogenesis Inhibitors ◽  
Anti Inflammatory

Angiogenesis Inhibitors. Drug Selectivity and Target Specificity

2007 ◽  
Vol 13 (27) ◽  
pp. 2795-2809 ◽  
Author(s):  
Georgios Kesisis ◽  
Henk Broxterman ◽  
Giuseppe Giaccone
Keyword(s):  
Angiogenesis Inhibitors ◽  
Target Specificity ◽  
Drug Selectivity
Sign in / Sign up

Export Citation Format

Share Document